VALIANT ORGANICS LIMITED (VALIANTORG) financials

VALIANT ORGANICS LIMITED (VALIANTORG) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1984, Valiant OrganicsLtd manufactures and deals in specialty chemicals and pharma intermediates[1]

Market Cap: ₹1,305Cr.
Current Price: ₹466
Stock P/E: 29.4
ROE: 4.00%
ROCE: 6.21%
Book Value: ₹249
Dividend Yield: 0.00%
52W High / Low: ₹508/195

In Jun 2026, VALIANT ORGANICS LIMITED (VALIANTORG) reported sales ₹232 Cr and net profit ₹22 Cr.

Annual TTM: sales ₹766 Cr, net profit ₹49 Cr.

Shareholding: Promoters 37.89% (Sep 2026), FIIs 0.44% (Sep 2026), DIIs 0.03% (Sep 2026), Public 61.65% (Sep 2026), No. of Shareholders 37,909% (Sep 2026).

VALIANTORG quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	160	187	204	204	157	159	218	232
Expenses	158	172	183	180	136	143	191	190
Operating Profit	2	15	21	25	21	16	26	42
OPM %	1.5%	8%	10%	12%	13%	10%	12%	18%
Other Income	2	5	1	1	0	7	4	3
Interest	8	6	5	6	4	5	3	5
Depreciation	9	9	9	9	10	10	10	10
Profit before tax	-13	6	7	10	7	8	17	29
Tax %	-12%	16%	44%	28%	24%	27%	11%	25%
Net Profit	-11	5	4	8	6	6	15	22
EPS in Rs	-4.04	1.68	1.41	2.71	2.00	2.16	5.40	7.78
Raw PDF	—	—	—	—	—	—	—	—

VALIANTORG profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	584	574	948	912	677	719	738	766
Expenses	410	417	783	782	638	665	650	661
Operating Profit	174	157	165	130	40	54	88	105
OPM %	30%	27%	17%	14%	6%	8%	12%	14%
Other Income	5	17	6	8	9	8	13	14
Interest	1	3	6	11	19	24	18	17
Depreciation	13	19	27	28	34	36	40	40
Profit before tax	165	152	137	100	-5	2	43	62
Tax %	25%	25%	25%	24%	-41%	224%	20%	—
Net Profit	124	115	103	76	-3	-3	34	49
EPS in Rs	51.00	42.20	37.91	27.83	-1.10	-1.07	12.26	17.34
Dividend Payout %	11%	12%	9%	4%	0%	0%	0%	—

VALIANTORG balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	12	27	27	27	28	28	28
Reserves	254	374	475	576	638	637	634	669
Borrowings	53	119	150	306	220	216	212	219
Other Liabilities	89	125	154	174	220	262	206	216
Total Liabilities	402	629	806	1,083	1,106	1,142	1,079	1,132
Fixed Assets	130	256	478	509	610	630	644	683
CWIP	66	129	46	110	70	86	66	21
Investments	20	34	42	53	53	54	54	64
Other Assets	187	210	240	410	373	371	315	365
Total Assets	402	629	806	1,083	1,106	1,142	1,079	1,132

VALIANTORG cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	77	160	115	-11	183	85	59	44
Cash from Investing Activity	-88	-191	-135	-120	-91	-65	-27	-39
Cash from Financing Activity	2	35	22	146	-109	-23	-28	-11
Net Cash Flow	-8	5	1	14	-17	-3	4	-6
Free Cash Flow	-6	-42	-37	-126	96	20	29	11
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	69%	115%	94%	10%	154%	218%	108%	47%

VALIANTORG shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	37.73%	37.91%	37.91%	37.91%	37.89%	37.89%	37.87%	37.89%
FIIs	0.82%	0.37%	0.21%	0.21%	0.22%	0.28%	0.21%	0.44%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%
Public	61.44%	61.72%	61.87%	61.86%	61.89%	61.82%	61.93%	61.65%
No. of Shareholders	49,017	48,077	44,293	43,274	42,311	40,928	40,526	37,909

VALIANTORG key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	73	69	74	97	85	113	88	120
Inventory Days	45	47	85	58	69	104	71	77
Days Payable	80	97	135	76	100	189	117	102
Cash Conversion Cycle	37	20	25	80	54	28	43	96
Working Capital Days	51	21	4	9	4	-7	-16	19
ROCE %	91%	41%	27%	18%	12%	1%	3%	6%

VALIANTORGUpdated 20 Oct 2026, 15:55

Valiant Organics Limited

VALIANTORGUpdated 20 Oct 2026, 15:55

Market Cap

₹1,305Cr.

Current Price

₹466

High / Low

₹508/195

Stock P/E

29.4

ROE4.00%

ROCE6.21%

Book Value₹249

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1984, Valiant OrganicsLtd manufactures and deals in specialty chemicals and pharma intermediates[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	177	4	156	6	8	14	25	10	3.82
Sep 2023	182	4	165	0	8	5	26	4	1.44
Dec 2023	141	4	138	0	9	-9	-22	-7	-2.43
Mar 2024	177	7	179	2	9	-16	-32	-11	-3.86
Jun 2024	168	5	152	0	9	2	118	0	-0.16
Sep 2024	160	8	158	2	9	-13	-12	-11	-4.04
Dec 2024	187	6	172	5	9	6	16	5	1.68
Mar 2025	204	5	183	1	9	7	44	4	1.41
Jun 2025	204	6	180	1	9	10	28	8	2.71
Sep 2025	157	4	136	0	10	7	24	6	2
Dec 2025	159	5	143	7	10	8	27	6	2.16
Mar 2026	218	3	191	4	10	17	11	15	5.4
Jun 2026	232	5	190	3	10	29	25	22	7.78

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	59	1	48	1	1	11	34	7	10.39
Mar 2016	52	0	36	1	1	16	35	10	14.03
Mar 2017	73	0	55	2	2	18	35	12	15.92
Mar 2018	121	0	94	1	2	25	35	16	13.97
Mar 2019	606	2	426	5	12	171	29	121	103.65
Mar 2020	584	1	410	5	13	165	25	124	51
Mar 2021	574	3	417	17	19	152	25	115	42.2
Mar 2022	948	6	783	6	27	137	25	103	37.91
Mar 2023	912	11	782	8	28	100	24	76	27.83
Mar 2024	677	19	638	9	34	-5	-41	-3	-1.1
Mar 2025	719	24	665	8	36	2	224	-3	-1.07
Mar 2026	738	18	650	13	40	43	20	34	12.26
TTM	766	17	661	14	40	62	—	49	17.34

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	37.89%
FIIs	0.44%
DIIs	0.03%
Public	61.65%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	37.9%	0.69%	0.87%	60.54%
Mar 2024	37.77%	1.14%	0.43%	60.65%
Jun 2024	37.77%	1.35%	0.09%	60.79%
Sep 2024	37.77%	1.34%	0.08%	60.8%
Dec 2024	37.73%	0.82%	0%	61.44%
Mar 2025	37.91%	0.37%	0%	61.72%
Jun 2025	37.91%	0.21%	0%	61.87%
Sep 2025	37.91%	0.21%	0%	61.86%
Dec 2025	37.89%	0.22%	0%	61.89%
Mar 2026	37.89%	0.28%	0%	61.82%
Jun 2026	37.87%	0.21%	0%	61.93%
Sep 2026	37.89%	0.44%	0.03%	61.65%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	0.36	21	8	11	40	11	1	2	26	40
Mar 2016	4	19	1	17	41	12	0	2	26	41
Mar 2017	4	42	1	23	69	26	0	7	35	69
Mar 2018	6	53	1	36	96	31	0	7	58	96
Mar 2019	6	254	53	89	402	130	66	20	187	402
Mar 2020	12	374	119	125	629	256	129	34	210	629
Mar 2021	27	475	150	154	806	478	46	42	240	806
Mar 2022	27	576	306	174	1083	509	110	53	410	1083
Mar 2023	27	638	220	220	1106	610	70	53	373	1106
Mar 2024	28	637	216	262	1142	630	86	54	371	1142
Mar 2025	28	634	212	206	1079	644	66	54	315	1079
Mar 2026	28	669	219	216	1132	683	21	64	365	1132

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	6	-1	-5	0
Mar 2016	18	-1	-16	0
Mar 2017	9	-1	-4	4
Mar 2018	18	-6	-5	7
Mar 2019	77	-88	2	-8
Mar 2020	160	-191	35	5
Mar 2021	115	-135	22	1
Mar 2022	-11	-120	146	14
Mar 2023	183	-91	-109	-17
Mar 2024	85	-65	-23	-3
Mar 2025	59	-27	-28	4
Mar 2026	44	-39	-11	-6

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	74	71	88	112	73	69	74	97	85	113	88	120
Inventory Days	42	36	97	44	45	47	85	58	69	104	71	77
Days Payable	7	50	130	154	80	97	135	76	100	189	117	102
Cash Conversion Cycle	110	57	55	2	37	20	25	80	54	28	43	96
Working Capital Days	53	59	69	41	51	21	4	9	4	-7	-16	19
ROCE %	43%	61%	52%	48%	91%	41%	27%	18%	12%	1%	3%	6%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of VALIANT ORGANICS LIMITED (VALIANTORG)?

The reported market capitalisation for VALIANT ORGANICS LIMITED (VALIANTORG) is ₹1,305Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of VALIANTORG?

The current price shown for VALIANT ORGANICS LIMITED (VALIANTORG) on Fincrux is ₹466 with a 52-week high/low of ₹508/195.

What is the P/E ratio of VALIANT ORGANICS LIMITED (VALIANTORG)?

The stock P/E for VALIANT ORGANICS LIMITED (VALIANTORG) is 29.4 on Fincrux, with ROE at 4.00% and ROCE at 6.21%.

What were VALIANTORG latest quarterly results?

For Jun 2026, VALIANT ORGANICS LIMITED (VALIANTORG) reported sales ₹232 Cr and net profit ₹22 Cr (figures in ₹ crore unless noted).

What are VALIANTORG annual sales and net profit?

For TTM, VALIANT ORGANICS LIMITED (VALIANTORG) shows sales of ₹766 Cr and net profit of ₹49 Cr on the Fincrux profit & loss statement.

Who owns VALIANT ORGANICS LIMITED (VALIANTORG)?

Latest shareholding for VALIANT ORGANICS LIMITED (VALIANTORG) on Fincrux: Promoters 37.89% (Sep 2026), FIIs 0.44% (Sep 2026), DIIs 0.03% (Sep 2026), Public 61.65% (Sep 2026), No. of Shareholders 37,909% (Sep 2026).

Where can I find VALIANT ORGANICS LIMITED (VALIANTORG) financials?

VALIANT ORGANICS LIMITED (VALIANTORG) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show VALIANTORG balance sheet and cash flow?

Yes. The VALIANT ORGANICS LIMITED (VALIANTORG) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 20 October 2026 at 15:55